Pituitary Cancer: Clinical Trials

3 trials for Pituitary Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Pituitary Cancer: new trials by email Literature Review of Pituitary Cancer trials Research Report on Pituitary Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Twenty-years' Experience in Pituitary Disease.
Frequency of disease recurrence - Pituitary Adenoma, Pituitary Cancer
RecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS16002025-03-102025-05-15
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
Ipilimumab, Nivolumab - Pituitary, Pituitary Tumor
Phase 2CompletedMemorial Sloan Kettering Cancer Center102019-07-312026-06-02
International PPB/DICER1 Registry
Pleuropulmonary Blastoma, Sertoli-Leydig Cell Tumor
RecruitingChildren's Hospitals and Clinics of Minnesota34002016-12-062026-10-26

Narrower conditions

Pituitary Neoplasms (3)  ·  Pituitary Diseases (2)  ·  Disease (1)  ·  Goiter, Nodular (1)  ·  Neuroblastoma (1)  ·  Pinealoma (1)  ·  Pleuropulmonary blastoma (1)  ·  Rhabdomyosarcoma, Embryonal (1)  ·  Sertoli-Leydig Cell Tumor (1)  ·  Sex Cord-Gonadal Stromal Tumors (1)  ·  Thyroid Neoplasms (1)  ·  Thyroid Nodule (1)  ·  Wilms Tumor (1)

Broader conditions

Brain Diseases (3)  ·  Brain Neoplasms (3)  ·  Central Nervous System Diseases (3)  ·  Central Nervous System Neoplasms (3)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Hypothalamic Diseases (3)  ·  Hypothalamic Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Nervous System Diseases (3)  ·  Nervous System Neoplasms (3)  ·  Supratentorial Neoplasms (3)  ·  Adnexal Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Ipilimumab (1)  ·  Nivolumab (1)

Sponsors

Children's Hospitals and Clinics of Minnesota (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Memorial Sloan Kettering Cancer Center (1)

Countries

United States (2)  ·  Italy (1)

Top investigators

Andrew Lin, MD (1)  ·  Francesco Doglietto, Prof (1)  ·  Kris Ann P Schultz, MD (1)

Results publications

PMID 19556464, PMID 25209242, PMID 27441995, PMID 28674120, PMID 29343557, PMID 30178239, PMID 30339877, PMID 30672147, PMID 30677214, PMID 30715996, PMID 30824630, PMID 31296931, PMID 31820118, PMID 31838154, PMID 31952842, PMID 32291395, PMID 32415267, PMID 33119505, PMID 33362722, PMID 33484847, PMID 33570641, PMID 33630087, PMID 33637876, PMID 33782093, PMID 33875804